Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme.

Ritter, A M

Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme. [electronic resource] - Neurosurgery Aug 1994 - 192-8; discussion 198 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0148-396X

10.1227/00006123-199408000-00003 doi


Adult
Aged
Brain--pathology
Brain Neoplasms--mortality
Bromodeoxyuridine
Cell Division--physiology
Chemotherapy, Adjuvant
Combined Modality Therapy
Female
Follow-Up Studies
Glioblastoma--mortality
Humans
Infusions, Intravenous
Male
Middle Aged
Mitotic Index
Neoplasm Recurrence, Local--mortality
Prognosis
Radiotherapy, Adjuvant
Reoperation
Survival Rate